MOTZER, ROBERT: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Kidney Cancer

Motzer, Robert J., Agarwal, Neeraj, Beard, Clair, Bolger, Graeme B., Boston, Barry, Carducci, Michael A., Choueiri, Toni K., Figlin, Robert A., Fishman, Mayer, Hancock, Steven L., Hudes, Gary R., Jona

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2009

Language:

english

File:

PDF, 504 KB

english, 2009

2

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Motzer, Robert J, Escudier, Bernard, Tomczak, Piotr, Hutson, Thomas E, Michaelson, M Dror, Negrier, Sylvie, Oudard, Stephane, Gore, Martin E, Tarazi, Jamal, Hariharan, Subramanian, Chen, Connie, Rosbr

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

3

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Motzer, Robert J., Penkov, Konstantin, Haanen, John, Rini, Brian, Albiges, Laurence, Campbell, Matthew T., Venugopal, Balaji, Kollmannsberger, Christian, Negrier, Sylvie, Uemura, Motohide, Lee, Jae L.

Journal:

New England Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 333 KB

english, 2019

4

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Motzer, Robert J, Hutson, Thomas E, Glen, Hilary, Michaelson, M Dror, Molina, Ana, Eisen, Timothy, Jassem, Jacek, Zolnierek, Jakub, Maroto, Jose Pablo, Mellado, Begoña, Melichar, Bohuslav, Tomasek, Ji

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 381 KB

english, 2015

5

Intra- and Interobserver Variability in CT Measurements in Oncology

McErlean, Aoife, Panicek, David M., Zabor, Emily C., Moskowitz, Chaya S., Bitar, Richard, Motzer, Robert J., Hricak, Hedvig, Ginsberg, Michelle S.

Journal:

Year:

2013

Language:

english

File:

PDF, 844 KB

english, 2013

6

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Tomita, Yoshihiko, Fukasawa, Satoshi, Shinohara, Nobuo, Kitamura, Hiroshi, Oya, Mototsugu, Eto, Masatoshi, Tanabe, Kazunari, Kimura, Go, Yonese, Junji, Yao, Masahiro, Motzer, Robert J., Uemura, Hirots

Journal:

Japanese Journal of Clinical Oncology

Year:

2017

Language:

english

File:

PDF, 517 KB

english, 2017

7

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214

Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Journal:

European Urology

Year:

2019

Language:

english

File:

PDF, 993 KB

english, 2019

8

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M Bukowski, M Dror Michaelson, George Wilding, Gary R Hudes, Oliver Bolte, Robert J Motzer, Paul Bycott, Katherine F Liau, James Freddo, Peter C Trask, Sinil Kim, Brian I Rini

Journal:

The Lancet Oncology

Year:

2007

Language:

english

File:

PDF, 143 KB

english, 2007

9

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Taylor, Matthew H., Lee, Chung-Han, Makker, Vicky, Rasco, Drew, Dutcus, Corina E., Wu, Jane, Stepan, Daniel E., Shumaker, Robert C., Motzer, Robert J.

Journal:

Journal of Clinical Oncology

Year:

2020

Language:

english

File:

PDF, 697 KB

english, 2020

10

Abdominal Pain Impacts Quality of Life in Women with Irritable Bowel Syndrome

Cain, Kevin C., Headstrom, Peggy, Jarrett, Monica E., Motzer, Sandra A., Park, Hyojung, Burr, Robert L., Surawicz, Christine M., Heitkemper, Margaret M.

Journal:

American Journal of Gastroenterology

Year:

2006

Language:

english

File:

PDF, 240 KB

english, 2006

11

Author Correction: Towards individualized therapy for metastatic renal cell carcinoma

Kotecha, Ritesh R., Motzer, Robert J., Voss, Martin H.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Year:

2019

File:

PDF, 148 KB

2019

12

A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

KATTAN, MICHAEL W., REUTER, VICTOR, MOTZER, ROBERT J., KATZ, JARED, RUSSO, PAUL

Journal:

The Journal of Urology

Year:

2001

Language:

english

File:

PDF, 81 KB

english, 2001

13

Using the Rasch Model to Validate and Enhance the Interpretation of the Functional Assessment of Cancer Therapy–Kidney Symptom Index—Disease-Related Symptoms Scale

Xuemei Luo, Joseph C. Cappelleri, David Cella, Jim Z. Li, Claudie Charbonneau, Sindy T. Kim, Isan Chen, Robert J. Motzer

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 140 KB

english, 2009

14

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Motzer, Robert J., Escudier, Bernard, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellan

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 551 KB

english, 2015

15

Increased Symptoms in Female IBS Patients With Dysmenorrhea and PMS

Altman, Gaylene, Cain, Kevin C., Motzer, Sandra, Jarrett, Monica, Burr, Robert, Heitkemper, Margaret

Journal:

Gastroenterology Nursing

Year:

2006

Language:

english

File:

PDF, 1.44 MB

english, 2006

16

Combination therapy for advanced and metastatic kidney cancer

Lee, Chung-Han, Motzer, Robert J.

Journal:

Nature Reviews Urology (formerly Nature Clinical Practice Urology)

Year:

2018

Language:

english

File:

PDF, 548 KB

english, 2018

17

Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma

Pal, Sumanta K., McDermott, David F., Atkins, Michael B., Escudier, Bernard, Rini, Brian I., Motzer, Robert J., Fong, Lawrence, Joseph, Richard W., Oudard, Stephane, Ravaud, Alain, Bracarda, Sergio, S

Journal:

BJU International

Year:

2020

File:

PDF, 10.34 MB

2020

18

TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS

Motzer, Robert J., Amsterdam, Alison, Prieto, Victor, Sheinfeld, Joel, Murty, V.V.V.S., Mazumdar, Madhu, Bosl, George J., Chaganti, R.S.K., Reuter, Victor E.

Journal:

The Journal of Urology

Year:

1998

Language:

english

File:

PDF, 1.35 MB

english, 1998

19

Immune Checkpoint Therapy in Renal Cell Carcinoma

Lee, Chung-Han, Motzer, Robert J.

Journal:

The Cancer Journal

Year:

2016

Language:

english

File:

PDF, 102 KB

english, 2016

20

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

Ged, Yasser, Gupta, Ruby, Duzgol, Cihan, Knezevic, Andrea, Shapnik, Natalie, Kotecha, Ritesh, Voss, Martin H., Feldman, Darren R., Akin, Oguz, Patil, Sujata, Motzer, Robert J., Rini, Brian I., Lee, Ch

Journal:

Year:

2020

File:

PDF, 826 KB

2020

21

Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy

Barbara A. Murphy, Robert J. Motzer, Madhu Mazumdar, Vaia Vlamis, Jerome Nisselbaum, Dean Bajorin, George J. Bosl

Journal:

Year:

1994

Language:

english

File:

PDF, 655 KB

english, 1994

22

Treatment outcome for metastatic papillary renal cell carcinoma patients

Ellen A. Ronnen, G. Varuni Kondagunta, Nicole Ishill, Lesley Spodek, Paul Russo, Victor Reuter, Jennifer Bacik, Robert J. Motzer

Journal:

Year:

2006

Language:

english

File:

PDF, 91 KB

english, 2006

23

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Brett E. Houk, Carlo L. Bello, Bill Poland, Lee S. Rosen, George D. Demetri, Robert J. Motzer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 912 KB

english, 2010

24

Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival

J. JAMES BRUNO II, MARK E. SNYDER, ROBERT J. MOTZER, PAUL RUSSO

Journal:

BJU International

Year:

2006

Language:

english

File:

PDF, 142 KB

english, 2006

25

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors

Darren R. Feldman, Lawrence H. Einhorn, David I. Quinn, Yohann Loriot, Johnathan K. Joffe, David J. Vaughn, Aude Fléchon, Julio Hajdenberg, Abdel-Baset Halim, Hamim Zahir, Robert J. Motzer…show all 11

Journal:

Investigational New Drugs

Year:

2013

Language:

english

File:

PDF, 240 KB

english, 2013

26

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

Rini, Brian I., Quinn, David I., Baum, Michael, Wood, Laura S., Tarazi, Jamal, Rosbrook, Brad, Arruda, Lillian Shahied, Cisar, Laura, Roberts, W. Gregory, Kim, Sinil, Motzer, Robert J.

Journal:

Targeted Oncology

Year:

2015

Language:

english

File:

PDF, 276 KB

english, 2015

27

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma

Motzer, Robert J., Hutson, Thomas E., Hudes, Gary R., Figlin, Robert A., Martini, Jean-Francois, English, Patricia A., Huang, Xin, Valota, Olga, Williams, J. Andrew

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2014

Language:

english

File:

PDF, 283 KB

english, 2014

28

Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Rini, Brian I., Escudier, Bernard, Hariharan, Subramanian, Roberts, W. Gregory, Tarazi, Jamal, Rosbrook, Brad, Askerova, Zena, DeAnnuntis, Liza L., Motzer, Robert J.

Journal:

Clinical Genitourinary Cancer

Year:

2015

Language:

english

File:

PDF, 612 KB

english, 2015

29

Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer

Motzer, Robert J., Sheinfeld, Joel, Mazumdar, Madhu, Bains, Manjit, Mariani, Tania, Bacik, Jennifer, Bajorin, Dean, Bosl, George J.

Journal:

Journal of Clinical Oncology

Year:

2000

File:

PDF, 52 KB

2000

30

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

Motzer, Robert J, Escudier, Bernard, McDermott, David F, ArÃ©n Frontera, Osvaldo, Melichar, Bohuslav, Powles, Thomas, Donskov, Frede, Plimack, Elizabeth R, BarthÃ©lÃ©my, Philippe, Hammers, Hans J, Geo

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2020

File:

PDF, 2.49 MB

2020

31

Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma

Peter J. Mencel, Lisa M. Deangelis, Robert J. Motzer

Journal:

Year:

1994

Language:

english

File:

PDF, 254 KB

english, 1994

32

Renal Cell Carcinoma Volume 528 || VEGF: Biologic Aspects and Clinical Approaches

Bukowski, Ronald M., Figlin, Robert A., Motzer, Robert J.

Year:

2009

Language:

english

File:

PDF, 282 KB

english, 2009

33

Contemporary Lymph Node Counts During Primary Retroperitoneal Lymph Node Dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren R. Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Year:

2011

Language:

english

File:

PDF, 224 KB

english, 2011

34

Body Mass Index Is Associated With Higher Lymph Node Counts During Retroperitoneal Lymph Node Dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Year:

2012

Language:

english

File:

PDF, 226 KB

english, 2012

35

Targeted drugs for metastatic renal cell carcinoma

Robert J Motzer, Ethan Basch

Journal:

Year:

2008

Language:

english

File:

PDF, 57 KB

english, 2008

36

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J Motzer, Bernard Escudier, Stéphane Oudard, Thomas E Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A Thompson, Robert A Figlin, Norbert Hollaender, Gladys Urbanowitz, William J

Journal:

Year:

2008

Language:

english

File:

PDF, 197 KB

english, 2008

37

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Motzer, Robert J., Hutson, Thomas E., Cella, David, Reeves, James, Hawkins, Robert, Guo, Jun, Nathan, Paul, Staehler, Michael, de Souza, Paul, Merchan, Jaime R., Boleti, Ekaterini, Fife, Kate, Jin, Ji

Journal:

New England Journal of Medicine

Year:

2013

Language:

english

File:

PDF, 624 KB

english, 2013

38

Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell Carcinoma

Adamy, Ari, Chong, Kian Tai, Chade, Daher, Costaras, James, Russo, Grace, Kaag, Matthew G., Bernstein, Melanie, Motzer, Robert J., Russo, Paul

Journal:

The Journal of Urology

Year:

2011

Language:

english

File:

PDF, 225 KB

english, 2011

39

Editorial: Predicting Necrosis After Chemotherapy for Advanced Nonseminomatous Germ Cell Tumor—Surrogate End Points, Decreasing Morbidity and Patient Outcome

Sheinfeld, Joel, Motzer, Robert

Journal:

The Journal of Urology

Year:

2004

Language:

english

File:

PDF, 53 KB

english, 2004

40

Renal Cell Carcinoma || Proteasome–NFκB Signaling Pathway: Relevance in RCC

Bukowski, Ronald M., Figlin, Robert A., Motzer, Robert J.

Year:

2009

Language:

english

File:

PDF, 407 KB

english, 2009

41

Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 Experience

Bazzi, Wassim M., Sjoberg, Daniel D., Feuerstein, Michael A., Maschino, Alexandra, Verma, Sweeney, Bernstein, Melanie, O’Brien, Matthew F., Jang, Thomas, Lowrance, William, Motzer, Robert J., Russo, P

Journal:

The Journal of Urology

Year:

2015

Language:

english

File:

PDF, 349 KB

english, 2015

42

Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor–Targeted Therapy for Renal Cell Carcinoma

Winer, Andrew G., Motzer, Robert J., Hakimi, A. Ari

Journal:

Urologic Clinics of North America

Year:

2016

Language:

english

File:

PDF, 291 KB

english, 2016

43

MP35-01 PROTEOMIC STRATIFICATION OF CLEAR CELL RENAL CELL CARCINOMA UTILIZING THE CANCER GENOME ATLAS (TCGA) WITH EXTERNAL VALIDATION

Kaffenberger, Samuel, Ciriello, Giovanni, Winer, Andrew, Voss, Martin, Maranchie, Jodi, Tamboli, Pheroze, Rathmell, Kimryn, Choueiri, Toni, Motzer, Robert, Coleman, Jonathan, Russo, Paul, Sander, Chri

Journal:

The Journal of Urology

Year:

2015

Language:

english

File:

PDF, 240 KB

english, 2015

44

The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions

Choueiri, Toni K., Motzer, Robert J.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2015

Language:

english

File:

PDF, 122 KB

english, 2015

45

Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group

Rini, Brian I., Hutson, Thomas E., Figlin, Robert A., Lechuga, Maria Josè, Valota, Olga, Serfass, Lucile, Rosbrook, Brad, Motzer, Robert J.

Journal:

Clinical Genitourinary Cancer

Year:

2018

Language:

english

File:

PDF, 879 KB

english, 2018

46

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

Powles, Thomas, Motzer, Robert J., Escudier, Bernard, Pal, Sumanta, Kollmannsberger, Christian, Pikiel, Joanna, Gurney, Howard, Rha, Sun Young, Park, Se Hoon, Geertsen, Poul F., Gross-Goupil, Marine,

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 560 KB

english, 2018

47

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma

Lee, Chung-Han, Motzer, Robert J., Glen, Hilary, Michaelson, M. D., Larkin, James, Minoshima, Yukinori, Kanekiyo, Michio, Ikezawa, Hiroki, Sachdev, Pallavi, Dutcus, Corina E., Funahashi, Yasuhiro, Vos

Journal:

British Journal of Cancer

Year:

2020

File:

PDF, 536 KB

2020

48

Optimal treatment for advanced seminoma?

Robert J. Motzer

Journal:

Year:

1993

Language:

english

File:

PDF, 173 KB

english, 1993

49

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

Revathi Suppiah, Philip E. Shaheen, Paul Elson, Seema A. Misbah, Laura Wood, Robert J. Motzer, Slyvie Negrier, Steven W. Andresen, Ronald M. Bukowski

Journal:

Year:

2006

Language:

english

File:

PDF, 129 KB

english, 2006

50

Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma

Teresa Murray Law, Peter Mencel, Robert J. Motzer

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 158 KB

english, 1994

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски